1-5 of 5
Xiuyu Cui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers

Karolina I. Woroniecka, Kristen E. Rhodin, Cosette Dechant, Xiuyu Cui, Pakawat Chongsathidkiet, Daniel Wilkinson, Jessica Waibl-Polania, Luis Sanchez-Perez, Peter E. Fecci
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1349–1358.
https://doi.org/10.1158/1078-0432.CCR-19-1068
Published: 13 March 2020
View articletitled, 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers
Open the PDF for 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers in another window
Includes: Supplementary data
Journal Articles

Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease

Hanna R. Kemeny, Aladine A. Elsamadicy, S. Harrison Farber, Cosette D. Champion, Selena J. Lorrey, Pakawat Chongsathidkiet, Karolina I. Woroniecka, Xiuyu Cui, Steven H. Shen, Kristen E. Rhodin, Vadim Tsvankin, Jeffrey Everitt, Luis Sanchez-Perez, Patrick Healy, Roger E. McLendon, Patrick J. Codd, Ian F. Dunn, Peter E. Fecci
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1141–1151.
https://doi.org/10.1158/1078-0432.CCR-18-3486
Published: 02 March 2020
View articletitled, Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease
Open the PDF for Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease in another window
Journal Articles

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen Rhodin, Hanna Kemeny, Cosette Dechant, S. Harrison Farber, Aladine A. Elsamadicy, Xiuyu Cui, Shohei Koyama, Christina Jackson, Landon J. Hansen, Tanner M. Johanns, Luis Sanchez-Perez, Vidyalakshmi Chandramohan, Yen-Rei Andrea Yu, Darell D. Bigner, Amber Giles, Patrick Healy, Glenn Dranoff, Kent J. Weinhold, Gavin P. Dunn, Peter E. Fecci
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (17): 4175–4186.
https://doi.org/10.1158/1078-0432.CCR-17-1846
Published: 04 September 2018
View articletitled, T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Open the PDF for T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Patrick C. Gedeon, Teilo H. Schaller, Satish K. Chitneni, Bryan D. Choi, Chien-Tsun Kuan, Carter M. Suryadevara, David J. Snyder, Robert J. Schmittling, Scott E. Szafranski, Xiuyu Cui, Patrick N. Healy, James E. Herndon, II, Roger E. McLendon, Stephen T. Keir, Gary E. Archer, Elizabeth A. Reap, Luis Sanchez-Perez, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (15): 3611–3631.
https://doi.org/10.1158/1078-0432.CCR-17-0126
Published: 31 July 2018
View articletitled, A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
Open the PDF for A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma in another window
Includes: Supplementary data
Journal Articles

Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells

Peter E. Fecci, Alison E. Sweeney, Peter M. Grossi, Smita K. Nair, Christopher A. Learn, Duane A. Mitchell, Xiuyu Cui, Thomas J. Cummings, Darell D. Bigner, Eli Gilboa, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4294–4305.
https://doi.org/10.1158/1078-0432.CCR-06-0053
Published: 20 July 2006
View articletitled, Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells
Open the PDF for Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells in another window